Phathom Pharmaceuticals Inc (PHAT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PHAT | AZN | AMGN | GILD | VRTX |
| Company | Phathom Pharmaceuticals Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 14.20 | 91.18 | 316.24 | 119.49 | 438.81 |
| High | 14.64 | 91.66 | 317.47 | 121.41 | 446.28 |
| Low | 14.12 | 89.70 | 313.00 | 118.78 | 433.81 |
| Latest | 14.55 | 91.51 | 315.38 | 121.34 | 444.64 |
| Change | +0.34 | +1.69 | +1.53 | +1.98 | +7.63 |
| % Change | +2.39% | +1.88% | +0.49% | +1.66% | +1.75% |
| Volume | 671,300 | 6,119,900 | 3,071,400 | 8,530,500 | 999,700 |
| 20-Day Average Volume | 823,545 | 5,578,250 | 2,943,185 | 7,234,880 | 1,396,275 |
| Previous Close | 14.21 | 89.82 | 313.85 | 119.36 | 437.01 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 14.77 | 90.41 | 335.90 | 124.46 | 436.18 |
| 20-Day Raw Stochastic | 30.71% | 63.08% | 7.13% | 25.84% | 57.61% |
| 20-Day Relative Strength | 54.06 | 60.68 | 46.32 | 48.75 | 56.61 |
| Weighted Alpha | +31.82 | +41.40 | +16.32 | +29.14 | -0.66 |
| Today's Opinion | 80% Buy | 100% Buy | 72% Buy | 72% Buy | 40% Buy |
| Previous Opinion | 80% Buy | 88% Buy | 72% Buy | 56% Buy | 24% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 56% Buy | 88% Buy | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.82% since 12/03/25 | +0.73% since 12/03/25 | -8.70% since 12/03/25 | -2.93% since 12/03/25 | -3.99% since 12/03/25 |
| Low | 14.12 on 12/10/25 | 89.67 on 12/08/25 | 313.00 on 12/10/25 | 118.78 on 12/10/25 | 433.81 on 12/10/25 |
| High | 15.14 on 12/09/25 | 91.66 on 12/10/25 | 346.33 on 12/04/25 | 124.96 on 12/04/25 | 463.70 on 12/04/25 |
| 1-Month | |||||
| %Chg | +5.97% since 11/10/25 | +4.61% since 11/10/25 | -2.56% since 11/10/25 | +2.70% since 11/10/25 | +5.57% since 11/10/25 |
| Low | 13.79 on 11/12/25 | 87.23 on 11/12/25 | 313.00 on 12/10/25 | 118.58 on 11/11/25 | 417.12 on 11/11/25 |
| High | 16.26 on 11/28/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | +18.10% since 09/10/25 | +13.24% since 09/10/25 | +13.24% since 09/10/25 | +5.28% since 09/10/25 | +14.44% since 09/10/25 |
| Low | 10.33 on 10/07/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 16.26 on 11/28/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | +62.21% since 06/10/25 | +23.95% since 06/10/25 | +7.48% since 06/10/25 | +10.22% since 06/10/25 | -1.52% since 06/10/25 |
| Low | 7.61 on 07/22/25 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 16.26 on 11/28/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,010,871 | 278,570,080 | 169,002,272 | 148,087,568 | 110,877,744 |
| Shares Outstanding, K | 71,138 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 55,250,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -334,330,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 49,500,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -29,970,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 0.43 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.15 on 10/30/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 03/05/26 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 09/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 11/21/25 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.97 | 14.69 | 14.80 | 28.87 |